Valuation: Cipla Limited

Market Cap 1,18900Cr 1.25TCr 1.09TCr 1.01TCr 933.58Cr 1.77TCr 1.8TCr 12TCr 4.69TCr 58TCr 4.68TCr 4.58TCr 2,02400Cr P/E 2027 *
28.3x
P/E 2028 * 23.1x
Enterprise Value 1,09100Cr 1.14TCr 1TCr 922.25Cr 856.06Cr 1.63TCr 1.65TCr 11TCr 4.3TCr 54TCr 4.29TCr 4.2TCr 1,85600Cr EV / Sales 2027 *
3.51x
EV / Sales 2028 * 3.07x
Free-Float
68.88%
Yield 2027 *
0.85%
Yield 2028 * 0.96%
1 day-0.68%
1 week-0.21%
Current month-0.21%
1 month+5.36%
3 months+21.62%
6 months-0.38%
Current year-3.24%
1 week 1,446
Extreme 1446
1,482
1 month 1,341.1
Extreme 1341.1
1,490.1
Current year 1,165.7
Extreme 1165.7
1,539.7
1 year 1,165.7
Extreme 1165.7
1,673
3 years 1,013
Extreme 1013
1,702.05
5 years 850
Extreme 850
1,702.05
10 years 355.3
Extreme 355.3
1,702.05
Manager TitleAgeSince
Chief Executive Officer - 01/04/2026
President - 18/05/2026
Director of Finance/CFO - 16/08/2022
Director TitleAgeSince
Chairman 90 21/07/1972
Director/Board Member 72 25/07/2014
Director/Board Member 71 30/06/2021
Date Insider Type Main position Quantity % Market Cap.
22/24/22Sell 2,000 0.0002%
14/24/14Sell 3,000 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
-0.65%-0.21%-3.19%+43.27% 1.25TCr
-0.18%+2.48%+13.62%+84.29% 4.81TCr
-1.41%+6.57%+71.07%+120.76% 3.79TCr
+0.27%+3.45%+15.24%+97.68% 1.2TCr
+0.96%+2.76%+34.19%+120.25% 902.96Cr
-0.16%+1.91%+22.31%+47.95% 724.14Cr
+0.41%+2.95%+56.10%-2.71% 708.74Cr
-0.62%+21.06%-16.02%+24.43% 653.53Cr
-0.82%+2.00%+20.88%+226.21% 671.84Cr
-1.85%-3.26%+24.60%+132.96% 441.68Cr
Average -0.43%+4.88%+23.88%+89.51% 1.51TCr
Weighted average by Cap. -0.51%+4.35%+29.72%+92.56%

Financials

2027 *2028 *
Net sales 31TCr 325.72Cr 285.26Cr 262.74Cr 243.88Cr 463.13Cr 469.39Cr 3.15TCr 1.22TCr 15TCr 1.22TCr 1.2TCr 53TCr 35TCr 363.52Cr 318.37Cr 293.23Cr 272.19Cr 516.87Cr 523.86Cr 3.51TCr 1.37TCr 17TCr 1.37TCr 1.34TCr 59TCr
Net income 4.2TCr 44Cr 39Cr 35Cr 33Cr 63Cr 63Cr 424.93Cr 165.37Cr 2.06TCr 165.26Cr 161.64Cr 7.14TCr 5.14TCr 54Cr 47Cr 43Cr 40Cr 77Cr 78Cr 520.49Cr 202.56Cr 2.52TCr 202.43Cr 197.99Cr 8.75TCr
Net Debt -9.88TCr -103.53Cr -91Cr -84Cr -78Cr -147.21Cr -149.2Cr -999.71Cr -389.06Cr -4.85TCr -388.81Cr -380.27Cr -17TCr -12TCr -131Cr -114.73Cr -105.67Cr -98Cr -186.26Cr -188.78Cr -1.26TCr -492.28Cr -6.13TCr -491.95Cr -481.16Cr -21TCr
Logo Cipla Limited
Cipla specializes in development, manufacturing and marketing of pharmaceutical products. The group provides prescription products and OTC medicines for the treatment of cardiovascular, ophthalmic and dermatological diseases, respiratory troubles, cancers, allergies, infections etc. Besides, Cipla develops and sells veterinary products. Net sales by source of income break down between sale of products (96.9%) and services (3.1%). Net sales are distributed geographically as follows: India (39.4%), the United States (18.5%), South Africa (17%) and other (25.1%).
Employees
31,369
Date Price Change Volume
07/26/07 1,462.70 -0.65% 7,13,451
06/26/06 ₹1,472.30 +0.97% 7,69,917
03/26/03 ₹1,458.20 +0.15% 12,61,674
02/26/02 ₹1,456.00 -0.05% 7,31,416
01/26/01 ₹1,456.70 -0.59% 7,53,439
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
37
Last Close Price
1,472.30INR
Average target price
1,463.62INR
Spread / Average Target
-0.59%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CIPLA Stock